Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07427680
Recruiting
Study of TGM-312-SC01 in Healthy Participants and Adults With MASH
Phase 1/2 · United Kingdom · 1 site
Registry update: 19 May 2026
NCT07370909
Recruiting
Evaluation of the Efficacy and Safety of Oral LW402 Tablets for the Treatment of Patients With Moderate-to-Severe Atopic Dermatitis
Phase 3 · China · 1 site
Registry update: 27 Aug 2026
NCT07249879
Recruiting
This Study is an Open-lable, Early Study to Evaluate the Safety, Feasibility, Cytokinetics, and Preliminary Efficacy of GC511B in DLL3+ Relapsed/Refractory Small Cell Lung Cancer.
Phase 1 · China · 2 sites
Registry update: 1 May 2026
NCT07321977
Recruiting
Assessment of a Portable Digital Device for Quantified Analysis of Markerless Walking in Volunteers With Neuromuscular Diseases or Asymptomatic Volunteers
Not applicable · France · 1 site
Registry update: 3 Nov 2026
NCT07429721
Recruiting
A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019A in Patients With Relapsed/Refractory Multiple Myeloma.
Early phase 1 · China · 1 site
Registry update: 22 Jul 2026
NCT06716489
Recruiting
Aerobic Exercise and Its Impact on Sensory, Musculoskeletal, and Psychosocial Aspects in Migraine
Not applicable · Brazil · 1 site
Registry update: 28 Apr 2026
2025-522970-35-00
Recruiting
The REVERT-PREDIABETES trial
Phase 4 · Denmark · 1 site
Registry update: 23 Nov 2025
NCT07271238
Recruiting
Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures
Not applicable · Croatia · 1 site
Registry update: 3 Nov 2026
NCT07164859
Recruiting
Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCI
Phase 3 · France · 16 sites
Registry update: 3 Nov 2026
2025-523478-17-00
Recruiting
Two initial aflibercept 8 mg loading doses in treatment-naive neovascular AMD
Phase 4 · Austria · 1 site
Registry update: 16 Feb 2026
NCT07571889
Recruiting
Topical Intranasal Anesthetic Block for Reducing the Pain of Botulinum Toxin Injections for Chronic Migraine
Not applicable · United States · 1 site
Registry update: 6 May 2026
NCT07090148
Recruiting
Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC
Phase 1 · United States · 1 site
Registry update: 11 Mar 2026
NCT07424547
Recruiting
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Phase 1 · United States · 5 sites
Registry update: 7 Apr 2026
NCT07378553
Recruiting
Multiparametric Ultrafast Ultrasound Biomarkers for Duchenne and Becker Muscular Dystrophies
Not applicable · France · 1 site
Registry update: 24 Jun 2026
NCT07436741
Recruiting
Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer
Phase 3 · China · 1 site
Registry update: 10 Jul 2026
2025-522922-11-00
Recruiting
A trial to assess the efficacy and safety of ACT-1004-1239 in adults with progressive multiple sclerosis
Phase 2 · Netherlands · 1 site
Registry update: 14 Sept 2026
NCT07456956
Recruiting
HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke
Not applicable · 1 site
Registry update: 25 Mar 2026
NCT07523542
Recruiting
SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus
Phase 1/2 · China · 1 site
Registry update: 13 Apr 2026
NCT07500220
Recruiting
Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC
Phase 1/2 · China · 1 site
Registry update: 30 Mar 2026
NCT07398664
Recruiting
H101 Plus TACE for r/m HNSCC
Phase 2 · China · 1 site
Registry update: 17 Jul 2026

Ordered by registry start date. Freshness and sponsorship never change the order.